Detalles de la búsqueda
1.
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database.
Haematologica
; 108(9): 2467-2475, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36951150
2.
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study.
Ann Hematol
; 102(9): 2459-2469, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37306711
3.
Intraoperative radiotherapy vs concurrent chemoradiotherapy in the treatment of patients with locally advanced pancreatic cancer.
Pancreatology
; 2021 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33933371
4.
Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study.
Am J Hematol
; 95(9): 1047-1056, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32449800
5.
Propensity score matching analysis of a phase II study on simultaneous modulated accelerated radiation therapy using helical tomotherapy for nasopharyngeal carcinomas.
BMC Cancer
; 17(1): 582, 2017 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-28851315
6.
Long-term efficacy and predictors of pembrolizumab-based regimens in patients with advanced esophageal cancer in the real world.
World J Gastroenterol
; 29(41): 5641-5656, 2023 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38077159
7.
Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphoma.
Cancer Rep (Hoboken)
; 6(5): e1800, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36919649
8.
Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database.
EJHaem
; 4(1): 78-89, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36819187
9.
Induction chemotherapy with albumin-bound paclitaxel plus lobaplatin followed by concurrent radiochemotherapy for locally advanced esophageal cancer.
World J Gastrointest Oncol
; 13(11): 1781-1790, 2021 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34853650
10.
Changes in the nutritional status of nine vitamins in patients with esophageal cancer during chemotherapy.
World J Gastroenterol
; 27(19): 2366-2375, 2021 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34040328
11.
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study.
Leukemia
; 35(6): 1671-1682, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32943751
12.
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making.
Leukemia
; 35(1): 130-142, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32152465
13.
[Efficacy of Liangxue Jiedu Huoxue Decoction in prevention of radiation pneumonitis: a randomized controlled trial].
Zhong Xi Yi Jie He Xue Bao
; 8(7): 624-8, 2010 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-20619137
14.
Neoadjuvant chemoradiotherapy plus surgery in the treatment of potentially resectable thoracic esophageal squamous cell carcinoma.
World J Clin Cases
; 8(24): 6315-6321, 2020 Dec 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33392312
15.
First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG.
Blood Adv
; 4(13): 3141-3153, 2020 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32658985
16.
Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG).
Aging (Albany NY)
; 11(19): 8463-8473, 2019 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31586991
17.
Effect of primary tumor invasion on treatment and survival in extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: a multicenter study from the China Lymphoma Collaborative Group (CLCG).
Leuk Lymphoma
; 60(11): 2669-2678, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31060406
18.
Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma.
JAMA Netw Open
; 2(3): e190194, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30821826
19.
Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group.
Blood Adv
; 2(18): 2369-2377, 2018 09 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30242098
20.
Risk-dependent curability of radiotherapy for elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG).
Cancer Med
; 7(12): 5952-5961, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30358175